Keyphrases
Doxorubicin
100%
Focused Ultrasound
100%
Diffuse Intrinsic Pontine Glioma
100%
Tumor
50%
Blood-brain Barrier
37%
Caelyx
37%
Liposomal Formulation
37%
Overall Survival
25%
Xenograft Model
25%
Bioluminescence Imaging
25%
Ultrasound Treatment
25%
Pontine
25%
Tumor Cells
12%
Effective Treatment
12%
Xenograft
12%
Microbubbles
12%
Engraftment
12%
No Significant Difference
12%
Orthotopic Injection
12%
Pontine Glioma
12%
Healthy Controls
12%
Treatment Effect
12%
Treatment Group
12%
Long Circulation
12%
Nude
12%
Drug Delivery System
12%
Rapid Recovery
12%
Preclinical Animal Models
12%
Recovery Time
12%
Non-invasive Method
12%
Long-term Exposure
12%
Liposomes
12%
Survival Analysis
12%
PEGylated
12%
Single Treatment
12%
Athymic
12%
Tumor Response
12%
Post Inoculation
12%
Imaging Monitoring
12%
Immunology and Microbiology
Xenograft
100%
Blood Brain Barrier
100%
Overall Survival
66%
Bioluminescence
66%
Tumor Cell
33%
Engraftment
33%
Microbubble
33%
Pharmacology, Toxicology and Pharmaceutical Science
Doxorubicin
100%
Pontine Glioma
100%
Neoplasm
45%
Blood-Brain Barrier
27%
Overall Survival
18%
Side Effect
9%
Antiinfective Agent
9%
Liposome
9%
Tumor Engraftment
9%
Extravasation
9%